research grants and awards history report · los angeles, ca karin smith research ... 1999–2000...

RECIPIENT INSTITUTION AWARD AMOUNT TITLE19

95–1

996

Beth Karlan, MDCedars-Sinai Medical CenterLos Angeles, CA

Karin Smith Research Grant in Ovarian Cancer

$50,000“Characterization of a Novel Ovarian Inhibitory Substance”

Jeffrey Fowler, MDOhio State University Columbus, OH

GCF Research Grant in Surgery

$50,000

“Laparoscopy Versus Laparotomy: An Evaluation of Adhesion Formation after Pelvic and Paraaortic Lymphadenectomy in a Porcine Model”

1996

–199

7

Stephen Rubin, MDUniversity of PennsylvaniaPhiladelphia, PA


$50,000“Adenovirus-Mediated Gene Therapy of Human Ovarian Cancer”

T. Scott Jennings, MDCardina Gynecologic Oncology Charleston, SC

GCF Research Grant in Surgery

$50,000

“Comparative Study of Crystalloid vs. Albumin Replacement in Patients with Ovarian Cancer and Ascites”

1997

–199

8

Andrew Berchuck, MDDuke University Medical Center Durham, NC


$50,000“Molecular-Epidemiology of Ovarian Cancer”

Richard Buller, MD, PhDUniversity of IowaIowa City, IA

Florence & Marshall Schwid Ovarian Cancer Research Grant

$50,000“Modulation of BRCA1 Expression in Ovarian Cancer: Screening Ramifications”

Jean Hurteau, MDUniversity HospitalIndianapolis, IN

Eva Metzger Research Grant in Ovarian Cancer

$50,000

“Regulation of Ovarian Cancer Cell Growth with Cyclin Dependent Kinase Inhibitor Gene Therapy”

Judith Wolf, MD

The University of Texas MD Anderson Cancer CancerHouston, TX

GCF Research Grant in Gynecologic Cancer

$25,000

“Evaluation of the Effect and Mechanism of Action of Adenovirus-Mediated Tumor Suppressor Gene Therapy of Ovarian Cancer”

1998

–199

9

Pamela Paley, MDUniversity of WashingtonSeattle, WA


$50,000“A Molecular Fingerprint of Angiogenesis in Epithelial Ovarian Cancer”

1999

–200

0

Terri Pustilnik,MDUniversity of AlabamaBirmingham, AL


$50,000

“A Dendritic Cell-based Vaccine Strategy for Ovarian Carcinoma Using the Novel Ovarian Tumor Marker Mesothelin”

Research Grants and Awards History Report


00–2

001

S. Diane Yamada, MDUniversity of ChicagoChicago, IL


$50,000“Evaluation of MKK4/SEKI Metastasis Suppressor Gene in Ovarian Carcinoma”

George Coukos, MD, PhD

University of PennsylvaniaPhiladelphia, PA

Bristol-Myers Squibb Oncology Young Investigator Grant

$50,000

“Impact of Cytotoxic Chemotherapy on Vaccine Therapy Strategies in Epithelial Ovarian Cancer”

Anil Sood, MDUniversity of Iowa Iowa City, IA

NOCC Ovarian Cancer Research Grant

$50,000“Role of FAK Expression in Invasion and Progression”

2000

–200

2

Ilana Cass, MDCedars-Sinai Medical CenterLos Angeles, CA

Susan G. Komen Breast Cancer Foundation Career Development Grant

$50,000 for 2 yrs.

“Effect of P53 Mutation Status on Cisplatin Chemosensitivity in Carcinomas with BRCA1 Mutations”

2001

–200

2

Elizabeth Swisher, MDUniversity of WashingtonSeattle, WA


$50,000

“Impact of Epigenetic Modulation of DNA Repair Genes on Chemoresistance and Survival in Ovarian Cancer”

Warner Huh, MDUniversity of AlabamaBirmingham, AL

Bristol-Myers Squibb Oncology Young Investigator Grant

$50,000

“Transduced Dendritic Cell Therapy for Cervical Cancer — Alternative Vector Targeting and Conjugate Strategies”

William Cliby, MDMayo ClinicRochester, MN

NOCC Ovarian Cancer Research Grant

$50,000“Validation of an Avian Ovarian Cancer Model”

2002

–200

3

Thomas Randall, MDPennsylvania HospitalPhiladelphia, PA


$50,000“Immunoregulatory Function of Tumor Endothelium”

Laura Havrilesky, MDDuke University Medical Center Durham, NC

Ann Schreiber Ovarian Cancer Research Grant

$50,000“Acetaminophen for the Primary Prevention of Ovarian Cancer”

J. Rebecca Liu, MDUniversity of MichiganAnn Arbor, MI


$50,000 for 2 yrs.

“Resveratrol Induced Apoptosis and Autophagocytosis in Ovarian and Breast Cancer”

David Cohn, MDOhio State UniversityColumbus, OH

Ovarian Cancer Research Grant

$50,000“Active Immunization with VEGF Peptides in the Treatment and Prevention of Ovarian Cancer”

Sharmila Makhija, MDUniversity of AlabamaBirmingham, AL


$50,000“Transcriptional Targeted Antiangiogenesis Gene Therapy for Ovarian Carcinoma”

Research Grants and Awards History Report (continued)


03–2

004

Robert Giuntoli, II, MDJohns Hopkins Medical Institutions Baltimore, MD


$50,000“Ex Vivo Expansion and Identification of Ovarian Cancer Cytotoxic T Lymphocytes”

Eugene Toy, MDUniversity of RochesterRochester, NY

Cytyc Corporation Gynecologic Cancer Grant

$50,000“PDIP38, a Novel Protein Marker for Early HPV Infection”

Matthew Anderson, MD


Eli Lilly and Company Ovarian Cancer Research Grant

$25,000“Dissecting the Role of AIB-1 in Ovarian Epithelial Invasiveness”

Cheryl Saenz, MDUniversity of CaliforniaSan Diego, CA


$50,000“Treatment of Terminal Metastatic Ovarian Cancer by Transducible Therapeutic siRNAs”

Linda Duska, MDMassachusetts General HospitalBoston, MA

GlaxoSmithKline Ovarian Cancer Research Grant

$25,000

“Testing the Significance of Cables Expression in Identifications and Genes of Endometrial Cancer”

Ronald Alvarez, MDUniversity of AlabamaBirmingham, AL

Kea Simon Ovarian Cancer Research Grant

$50,000

“Melanoma Differentiation Associated-7 (mda-7) Gene: A Novel Multifunctional Anti-Tumor Agent for Ovarian Cancer”

Robert Burger, MDUniversity of California — Irvine Medical Center Orange, CA


$25,000“The Role of ECA1 in Ovarian Carcinogenesis and Potential Utility as a Serum Marker”

Christina Chu, MDUniversity of PennsylvaniaPhiladelphia, PA


$50,000

“Modification of Ovarian Tumor to Function as Primary Antigen Presenting Cells for Allogeneic Vaccination”

2004

–200

5

Rosemarie Schmandt, PhD



$50,000“What is the Role of BRK in Ovarian Tumor Growth?”

Mark Einstein, MDAlbert Einstein College of MedicineBronx, NY

Anonymous Cervical Cancer Research Grant

$25,000“Role of Genetic Variants in Cervical Cancer Risk”

Joseph Connor, MDUniversity of Wisconsin Madison, WI

Anonymous Ovarian Cancer Research Grant

$50,000“Intraperitoneal Therapy with huKS-IL2 in a Mouse Model of Epithelian Ovarian Cancer”

David O’Malley, MDYale University School of MedicineNew Haven, CT

Eli Lilly & Company Ovarian Cancer Research Grant

$50,000

“Characterize the Molecular Mechanisms Regulating the Sensitivity of Ovarian Cells to Apoptosis Induced by Phenoxodiol”



04–2

005

Amir Jazaeri, MDUniversity of VirginiaCharlottesville, VA


$50,000“Evaluation of the MEIS1 Gene as Potential Biomarker for Ovarian Cancer”

John Chan, MDStanford University School of MedicineStanford, CA

GlaxoSmithKline Therapeutic Approaches to Relapsed Ovarian Cancer Grant

$25,000“Dual Therapy of Epithelial Ovarian Cancer”

Andrew Li, MDCedars-Sinai Medical CenterLos Angeles, CA


$50,000“Androgen Modulation of EGFR Signaling in Epithelial Ovarian Cancer Biology”

Christine Walsh, MDCedars-Sinai Medical CenterLos Angeles, CA

Lee Kaplan Cancer Foundation Ovarian Cancer Research Grant

$25,000“Defining the Role of HNPCC in Women with Synchronous Ovarian and Endometrial Cancers”

Johnathan Lancaster, MDMoffitt Cancer CenterTampa, FL

Molly Cade Ovarian Cancer Research Grant

$50,000

“Reversal of Platinum Resistance in Ovarian Cancer Cell Lines by Silencing of Gene Expression Pathways using RNA Interference”

Peter Argenta, MDUniversity of MinnesotaMinneapolis, MN


$50,000 for 2 yrs.

“The Relative Expression and Activity Levels of Steroid-Converting Enzyme Isoforms in Breast and Ovarian Cancers”

Heidi Gray, MDUniversity of WashingtonSeattle, WA

R.O.C.C.S. Ovarian Cancer Research Grant

$25,000

“Early Cancer Detection in High Risk Patient using an Ovarian Cancer Specific Immunologic Screen”

2005

–200

6

Robert Coleman, MD

The University of Texas MD Anderson Cancer CenterHouston, TX


$50,000“Therapeutic Gene Silencing with siRNA in Ovarian Carcinoma”

Ernst Lengyel, MD, PhDUniversity of Chicago Medical CenterChicago, IL


$50,000

“Establishment of a Peritoneal 3D Culture to Investigate Attachment and Invasion of Ovarian Cancer Cells”

Gloria Huang, MDAlbert Einstein College of MedicineBronx, NY


$50,000

“Role of Insulin-Like Growth Factor Signaling as a Novel Therapeutic Target in Ovarian Cancer”

Takiko Daikoku, PhDVanderbilt University Medical CenterNashville, TN


$50,000“PPARs is a Downstream Target of COX-1 Dervied Prostaglandins in Ovarian Cancer”

Kerry Rodabaugh, MDRoswell Park Cancer InstituteBuffalo, NY

Anonymous Ovarian Cancer Research Grant

$50,000

“Genomic Rearrangement: Their Association with Hereditary Ovarian Cancers & Genetic Testing”



05–2

006

Ruea-Yea Huang, MDRoswell Park Cancer InstituteBuffalo, NY


$50,000

“Evaluation of Genes in the Nonsense-Mediated mRNA Decay Pathway as Potential Biomarkers for Ovarian Cancer”

Vivian von Gruenigen, MD

University Hospitals of Cleveland MacDonald Women’s HospitalCleveland, OH

St. Louis Ovarian Cancer Awareness Research Grant

$25,000

“Strategies to Improve the Quality of Life in Women with Ovarian Cancer on Adjuvant Chemotherapy”

2006

–200

7

Jonathan Hickson, PhDUniversity of Chicago Medical Center Chicago, IL


$50,000

“Identification of Downstream Effectors and Biological Outcomes of MKK4-Mediated Metastasis Suppression in Ovarian Cancer”

Joelle Hillion, PhDJohns Hopkins University Baltimore, MD

Susan A. Olde Endometrial Cancer Research Grant

$50,000 “HMGA1 in Endometrial Cancer”

Douglas Levine, MDMemorial Sloan Kettering Cancer Center New York, NY

Anne B. Kingsley Ovarian Cancer Foundation Research Grant

$50,000“MicroRNA Gene Expression in Advanced Ovarian Cancer”

Kwong-Kwok Wong, PhD

The University of Texas MD Anderson Cancer Center Houston, TX


$50,000“Prognostic Marker for Low-Grade Serious Ovarian Carcinoma”

Sarah Adams, MDUniversity of Pennsylvania Philadelphia, PA


$50,000“Development of Immunotherapy for Ovarian Cancer Using Ascites Antigen-Presenting Cells”

Neil Horowitz, MDMassachusetts General Hospital Boston, MA


$50,000“Leptin and its Role in Ovarian Tumorogenesis”

Monique Spillman, MD, PhD

University of Colorado Denver, CO


$50,000 for 2 yrs.

“Steroid Hormone Regulation of Extraperitoneal Ovarian Cancer Metastases in Mouse Models”

2007

–200

8

Jason Wright, MDColumbia University New York, NY


$50,000“Therapeutic Targeting of FSH in Epithelial Ovarian Cancer”

Oliver Dorigo, MD, PhDUniversity of California — Los Angeles Los Angeles, CA


$50,000

“Effect of Dual mTOR and Pl3kinase Inhibition on Ovarian Cancer Cells Inculture and in Vivo”

Mian M.K. Shahzad, MD

Baylor College of Medicine and The University of Texas MD Anderson Cancer Center Houston, TX


$50,000“Gene Expression Differences in Wound Versus Tumor Angiogenesis”



07–2

008

Melissa Merritt, PhDBrigham and Women’s Hospital Boston, MA


$50,000

“Role of Ovarian Stromal Microenvironment in Carcinogenic Transformation of Putative Precursor Cells for Pelvic Serous Cancer”

Sanaz Memarzadeh, MDUniversity of California — Los Angeles Los Angeles, CA


$50,000“Identification of Ovarian Surface Epithelial Stem Cells and their Role in Cancer Initiation”

Kathleen Moore, MDOU Health Sciences Center Oklahoma City, OK

Kathy Jean Warnick Ovarian Cancer Research Grant

$25,000

“The Role of Ribonucleotide Reductase Regulatory Subunit 1 and Excision Repair Cross-Complementation Group 1 in Determining Chemo-Sensitivity in Ovarian Cancer”

Sean Dowdy, MDMayo Clinic Rochester, MN

Susan A. Olde Endometrial Cancer Research Grant

$50,000“Evolution of the Tumorigenic Effects of DNA Methyltransferase 3B in Endometrial Cancer”

2008

–200

9

Alpa Nick, MDThe University of Texas MD Anderson Cancer Center Houston, TX


$50,000“Breath Biomarkers for Detection of Ovarian Cancer”

John Liao, MD, PhDUniversity of Pennsylvania Philadelphia, PA


$50,000

“Human Peripheral Blood Lymphocytes Expressing a Murine Anti-p53 T Cell Receptor for Ovarian Cancer Immunotherapy”

Robert Wenham, MDMoffitt Cancer Center Tampa, FL


$50,000

“The Role of 14.3.3 in Ovarian Cancer Cell AKT-Mediated Apoptosis; A Potential New Target for Overcoming Chemoresistance”

Charles Landen, MDUniversity of Alabama Birmingham, AL

Sarah Biedenharn Ovarian Cancer Research Grant in honor of Ellen Smith, MD

$50,000“Targeting the Notch Pathway in Ovarian Cancer Stem Cells”

Premal Thaker, MDWashington University School of Medicine St. Louis, MO


$40,000“Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients”

Dineo Khabele, MDVanderbilt University Nashville, TN

Mary-Jane Welker and Sherri’s From A Whisper to a Roar Ovarian Cancer Research Grant

$25,000“Selective Targeting of HDAC3 in Ovarian Cancer”



09–2

010

Koji Matsuo, MDThe University of Texas MD Anderson Cancer Center Houston, TX


$50,000“New Anti-Angiogenic Strategies Using “Smart” Biocompatible Nanoparticles”

Wei Hu, MD, PhDThe University of Texas MD Anderson Cancer Center Houston, TX


$50,000“Reversing VEGF Resistance with Dll4-Notch Inhibition in Ovarian Cancer”

Andrea Hagemann, MDUniversity of Pennsylvania Philadelphia, PA


$50,000

“Development of Genetically-Optimized Whole Tumor Cell Vaccines for Epithelial Ovarian Cancer”

Rebecca Stone, MDThe University of Texas MD Anderson Cancer Center Houston, TX

Gail MacNeil KOH Research Grant for Early Detection of Ovarian Cancer

$50,000“Unplugging Ovarian Cancer from the Power of Platelets”

Iris Romero, MDThe University of Chicago Medical Center Chicago, IL


$25,000“The Use of Metformin and Ovarian Cancer Prognosis”

Fiona Simpkins, MDUniversity of Miami Miami, FL

Mary-Jane Welker Ovarian Cancer Research Grant

$50,000

“Targeting the MEK Signaling Pathway in Combination with ER Blockade or PI3K/MTOR Inhibition in Ovarian Cancer Cells”

Rodney Rocconi, MDUniversity of South Alabama Mobile, AL

Sherri’s From A Whisper to a Roar Ovarian Cancer Research Grant

$33,000“Discovery of Molecular Targets in Ovarian Cancer Stem Cells”

2010

–201

1

Victoria Lin Bae-Jump, MD, PhD

University of North Carolina at Chapel Hill


$50,000Cross-Species Investigation of the Impact of Obesity on Ovarian Cancer Pathogenesis

Melissa Geller, MDRegents of the University of Minnesota

Caring Together, NY Ovarian Cancer Research Grant

$50,000

The Role of Proteasome Inhibition on Death Receptor in Ovarian Cancer to Potentiate Natural Killer Cell Cytotoxicity

Yvonne Lin-Liu, MDUniversity of Southern California


$25,000

The Putative Mechanisms of Nutritional Excess and Endoplasmic Reticulum (ER) Stress on Ovarian Cancer Chemoresistance

Claire Mach, PharmD University of HoustonCarol’s Cause Endometrial Cancer Research Grant

$25,000A MicroRNA-Based Strategy for Targeting Uterine Papillary Serous Carcinoma

Greg Sfakianos, MD Duke University

Ovarian Cancer National Alliance Ovarian Cancer Research Grant

$50,000Gene Regulation in RecurrentOvarian Cancer



10–2

011

W. Ruprecht Wiedemeyer, PhD

Cedars-Sinai Medical Center

Mary-Jane Welker Ovarian Cancer Research Grant; Special thanks to Dr. Lynne Knowles

$50,000Biomarkers Predicting Response to Cyclin-Dependent Kinase Inhibitors in Ovarian Cancer

Mai Xu, MD, PhDWashington University School of Medicine

Gail MacNeil KOH Research Grant for Early Detection of Ovarian Cancer

$50,000Development of Reagents for Ovarian Cancer Imaging and Targeted Therapy

2011

–201

2

Justin Bottsford-Miller, MD

University of Texas MD Anderson Cancer Center

Ovarian Cancer National Alliance Ovarian Cancer Research Grant

$50,000

Fuel on the Fire: Understanding the Influence of Platelets on Chemotherapy Response in Ovarian Cancer

Michael Goodheart, MD University of IowaCarol’s Cause Endometrial Cancer Research Grant

$25,000Wnt/Lef-1 Regulation of Endometrial Gland Growth

Petar Jelinic, PhDSloan-Kettering Institute for Cancer Research


$50,000

EMSY-mediated Suppression of Homology-directed Repair- Expanding the Arena of PARP Inhibitors in Ovarian Cancer

Erin King, MD, MPHUniversity of Texas MD Anderson Cancer Center


$25,000

Progestagen-Associated Endometrial Protein (PAEP): A Novel Tumor Suppressor Gene with Therapeutic Implications in Low-grade Serous Ovarian Carcinomas

Andras Ladanyi, MD, PhD

University of Chicago Hospitals

Amgen Ovarian Cancer Research Grant

$50,000

The Role of Plasminogen Activator Inhibitor-1 Expression in Cancer-Associated Fibroblasts in High-Grade Serous Ovarian Cancers

Jung-Min Lee, MD National Cancer InstituteCaring Together, NY Ovarian Cancer Research Grant

$50,000

High γH2AX/Rad51 Ratio Is a Predictive Biomarker for Response to PARP Inhibitor Therapy in High Grade Serous Mullerian Cancers

2012

–201

3

Angeles Alvarez Secord, MD, MHSc

Duke UniversityFlorence & Marshall Schwid Ovarian Cancer Research Grant

$50,000

Biomarker Discovery to Direct Bevacizumab Therapy in Ovarian Cancer – Blood-based Angiome Profiling

Paul-Joseph Aspuria, PhD

Cedars-Sinai Medical Center

Lynette Medlin-Brumfield/Mary-Jane Welker Ovarian Cancer Early Detection Research Grant

$50,000Development of a Non-Ionizing Radiation Imaging Modality for Early Ovarian Cancer Detection

Thanh Dellinger, MDBeckman Research Institute of City of Hope

Athena’s Run for GYN Cancers, Ovarian Cancer Research Grant

$50,000

Therapeutic Potential of Targeting Twist1 in Preventing Metastasis and Chemoresistance in Epithelial Ovarian Cancer (EOC)

Michael Goldberg, PhDDana-Farber Cancer Institute


$50,000

A Novel Combinatorial Approach to Address Immunosuppression and Proliferation in Ovarian Cancer


RECIPIENT INSTITUTION AWARD AMOUNT TITLE

2012

–201

3

Jesus Gonzalez-Bosquet, MD, PhD

H. Lee Moffitt Cancer Center & Research Inst.


$25,000

Identification of Regulatory Elements Associated with Ovarian Cancer Chemo-response Through Integration of Biological Data

Meera Nanjundan, PhD University of South FloridaThe Braverman/Rudnick Family Grant in Ovarian Cancer Research

$25,000

Role of Autophagy in the Transition from Endometriosis to Endometriosis-Associated Ovarian Cancers

Caitlin Stashwick, MDThe University of Pennsylvania

Johanna’s Fund Ovarian Cancer Research Grant

$25,000

Overcoming B7-H4 Mediated T-cell Inhibition and Tumor Immune Evasion in Ovarian Cancer with a Novel Chimeric Protein

Yunfei Wen, PhDUniversity of Texas MD Anderson Cancer Center


$50,000Promoting Suicidal Autophagy in Ovarian Cancer by Blocking Prolactin

2013

–201

4

Rebecca C. Arend, MDUniversity of Alabama at Birmingham

WeRoc/OChO Ovarian Cancer Research Grant

$50,000Wnt/B-catenin pathway as a target for the treatment of ovarian cancer

Stephanie Jean, MD University of PennsylvaniaSt. Louis Ovarian Cancer Awareness Research Grant

$50,000

Understanding BRCA-associated tumor evolution using targeted next generation sequencing of normal, precursor, and malignant tissue

Marianne Kim, PhD National Cancer InstituteAmgen Ovarian Cancer Research Grant

$50,000From therapeutic targets to clinical strategies

Paula S. Lee, MD, PhD Duke UniversityGenentech Ovarian Cancer Research Grant

$50,000A Pilot Study on H.O.P.E.: Helping Ovarian Cancer Patients Cope During Disease Recurrence

Sherry Y. Wu, PhDUniversity of Texas MD Anderson Cancer Center


$100,000Novel microRNA-based immunos-timulatory strategies for treatment of ovarian cancer

Melinda S. Yates, PhDUniversity of Texas MD Anderson Cancer Center

Roberta Detz Endometrial Cancer Research Grant

$50,000Endometrial specific knockout of MSH2: Characterization of a mouse model for lynch syndrome



14–2

015

Paiman Peter Ghoroghchian, MD, PhD

Dana-Farber Cancer Institute (DFCI)/Massachusetts Institute of Technology (MIT)


$50,000Novel therapies for platinum resistant ovarian cancer

Yi-Wen Huang, PhDMedical College of Wisconsin

Athena’s Run Endometrial Cancer Research Grant

$50,000Targeting the miR-137-KDM1 axis as a therapeutic strategy for high-grade endometrial carcinomas

Piotr Dorniak, PhDThe University of Texas MD Anderson Cancer Center

2014–15 Caring Together, NY Ovarian Cancer Research Grant

$100,000Tumor neurogenesis: novel mechanisms for targeting ovarian cancer

Xiaowen Hu, PhD University of PennsylvaniaGynecologic Cancer Research Grant

$45,000

Characterization of a novel recurrent noncoding genomic alteration in high grade serous ovarian cancer

Dmitriy Zamarin, MD, PhD

Memorial Sloan Kettering Cancer Center

The Judith Liebenthal Robinson Ovarian Cancer Foundation Research Grant

$50,000

Immunologic biomarkers of response to immunotherapy in platinum-resistant relapsed ovarian cancer

Katherine Fuh, MD, PhDWashington University School of Medicine


$75,000Functional genomics of metastatic ovarian cancer


RECIPIENT AWARD AMOUNT TITLE19

95–1

999

Terri Cornelison, MDGCF/NCI Research Training Fellowship

$100,000“Prevention of Late Effect Radiation Fibrosis by Cytokine Inhibition”

1999

–200

3

Monica Brown, MDGCF/NCI Research Training Fellowship

$100,000“Gene Expression Profiling in Ovarian Neoplasms”

2000

–200

4

Ginger Gardner, MDGCF/NCI Research Training Fellowship

$100,000“The Development and Characterization of Novel Retinoids for the Chemoprevention and Treatment of Ovarian Cancer”

2000

–200

4

Amir Jazaeri, MDGCF/NCI Research Training Fellowship

$100,000“Use of cDNA Microarrays in Evaluation of Ovarian Cancer”

2001

–200

5

Kristin Zorn, MDGCF/NCI Research Training Fellowship

$100,000“Gene Expressions Profile of Ovarian Cancer Histologic Suptypes”

NOTE: The salary of each fellow was matched equally by NCI.

National Cancer Institute Fellows History Report

RECIPIENT INSTITUTION AWARD AMOUNT

2006

–200

8

Jesus Gonzalez Bosquet, MD, PhDMayo Clinic Rochester, MN

GCF/NCI Scholar’s Program $100,000

NOTE: The salary of this scholar was matched equally by NCI.

National Cancer Institute Scholars History Report

Recipients of Outstanding Paper by a Resident or Fellow History Report

YEAR RECIPIENT

1994 Jeffrey Hines, MD

1995 Jeffrey Skilling, MD

1996 Jeffrey Skilling, MD

1997 Cheryl Bailey, MD

1998 J. Rebecca Liu, MD

1999 David Kushner, MD

2000 Douglas Levine, MD

2001 Warner Huh, MD

2002 Annie Yessaian, MD

2003 Nicholas Lambrou, MD

2003 Kristin Zorn, MD

2004 Rahel Ghebre, MD

2005 Lynne Knowles, MD

2005 Premal Thaker, MD

YEAR RECIPIENT

2006 Michael Milam, MD

2006 Charles Landen, MD

2007 William Merritt, MD

2007 Liz Han, MD

2008 Kimberly Resnick, MD

2008 Liz Han, MD

2009 Jason Cory Barnett, MD

2009 Karen McLean, MD, PhD

2010 Barbara Norquist, MD

2011 Nicole Fleming, MD

2012 Stephanie L. Wethington, MD

2014 Justin Bottsford-Miller, MD

2014 Linda Hong, MD

Foundation for Women’s Cancer/OCRF Grant for Early Detection of Ovarian Cancer History Report

RECIPIENT INSTITUTION AWARD AMOUNT TITLE

2008

–200

9

Barbara Goff, MD University of Washington

Foundation for Women’s Cancer/OCRF Grant for Early Detection of Ovarian Cancer

$300,000Symptom Triggered Screening for Ovarian Cancer: A Pilot Study of Feasibility and Acceptability

Perlman Family CCARE Lynch Syndrome Research Prize History Report

YEAR RECIPIENT

2012–2013 Miya M. Frick

2013–2014 Erin E. Greenberg, MD

YEAR RECIPIENT

2014–2015 Joshua G. Cohen, MD

RECIPIENT INSTITUTION AWARD TITLE

2004

–200

5


University of PennsylvaniaPhiladelphia, PA

Margaret Greenfield/Carmel Cohen, MD “Excellence in Ovarian Cancer Research Prize”

“Impact of Cytotoxic Chemotherapy on Vaccine Therapy Strategies in Epithelial Ovarian Cancer”

2005

–200

6

Andrew Berchuck, MDDuke University Medical CenterDurham, NC


“Molecular Epidemiology of Ovarian Cancer”

2006

–200

7

Anil Sood, MDThe University of Texas MD Anderson Cancer Center Houston, TX


“Role of FAK Expression in Invasion and Progression”

2007

–200

8

Beth Karlan, MDCedars-Sinai Medical Center Los Angeles, CA


“Characterization of a Novel Ovarian Inhibitory Substance”

2008

–200

9

Ronald Alvarez, MDUniversity of Alabama Birmingham, AL


“Melanoma Differentiation Associated-7 (mda-7) Gene: A Novel Multifunctional Anti-Tumor Agent for Ovarian Cancer”

2009

–201

0

Elizabeth Swisher, MDUniversity of Washington Seattle, WA


“Impact of Epigenetic Modulation of DNA Repair Genes on Chemoresistance and Survival in Ovarian Cancer”

2010

–201

1

Robert Coleman, MDThe University of Texas MD Anderson Cancer Center


“Therapeutic Gene Silencing with siRNA in Ovarian Carcinoma

Margaret Greenfield/Carmel Cohen, MD “Excellence in Ovarian Cancer Prize” History Report

Dr. John L. Lewis, Jr./William F. O’Connor Foundation Research Prize History Report

YEAR RECIPIENT

2013–2014 Mythili Koneru, MD

John L. Lewis, Jr., MD Presidential Award History ReportYEAR RECIPIENT

2013–2014 Jerome Belinson, MD

YEAR RECIPIENT

2014–2015 Kemi M. Doll, MD

YEAR RECIPIENT

2014–2015 Ramez Eskander, MD


2009

–201

0

Paul Goodfellow, PhDWashington University School of Medicine St. Louis, MO

Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher

“Genetic and Epigenetic Events Associated with Endometrial Tumorigenesis and Endometrial Cancer Progression”

2010

–201

1

Anil Sood, MDUniversity of Texas MD Anderson Cancer Center


“Ovarian Cancer Biology; Angiogenesis; Nanotechnology; Translational Research”

2011

–201

2


University of Pennsylvania


“Prevention, Early Detection and Treatment of Ovarian Cancer”

2012

–201

3

Robert C. Bast Jr., MDUniversity of Texas MD Anderson Cancer Center


“Cellular and Molecular Biology of Ovarian and Breast Cancer; Tumor Biomarkers; Medical Oncology with Emphasis on Caring for Patients with Ovarian and Breast Cancer; Translational Research with Emphasis on Academe-Pharma Interactions and on Mentoring Physician-scientists, Clinician-investigators an Translational PhDs”

2013

–201

4

Andrew Berchuck, MDDuke University Medical Center


“Molecular Pathogenesis of Ovarian Cancer”

2014

–201

5

Beth Y. Karlan, MDCedars-Sinai Medical Center


“Characterization of a Novel Ovarian Inhibitory Substance”

Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher History Report


2011

–201

2

Ernst Lengyel, MD, PhD

University of ChicagoFoundation for Women’s Cancer Excellence in Ovarian Cancer Research Prize

“Establishment of a Peritoneal 3D Culture to Investigate Attachment and Invasion of Ovarian Cancer Cells”

2012

–201

3

Douglas A. Levine, MDMemorial Sloan-Kettering Cancer Center

Foundation for Women’s Cancer Excellence in Ovarian Cancer Research Prize in Honor of Ronald Alvarez, MD

“MicroRNA Gene Expression in Advanced Ovarian Cancer”

2013

–201

4

Janice Rebecca Liu, MD

University of Michigan Medical Center

Foundation for Women’s Cancer/Norma Livingston Ovarian Cancer Foundation Excellence in Ovarian Cancer Research Prize in Honor of Ronald Alvarez, MD

“Gynecologic Cancer Foundation/Susan G. Komen Breast Cancer Foundation Career Development Award: Resveratrol Induced Apoptosis and Autophagocytosis in Ovarian and Breast Cancer”

2014

–201

5

Jason Dennis Wright, MD

Columbia University College of Physicians and Surgeons

Foundation for Women’s Cancer/Norma Livingston Ovarian Cancer Foundation Excellence in Ovarian Cancer Research Prize in Honor of Ronald Alvarez, MD

“Measuring the Quality of Surgical Care for Women with Ovarian Cancer”

Foundation for Women’s Cancer “Excellence in Ovarian Cancer Research Prize” in honor of Ronald Alvarez, MD History Report

research grants and awards history report · los angeles, ca karin smith research ... 1999–2000...

Documents